0001415889-18-001611.txt : 20181113 0001415889-18-001611.hdr.sgml : 20181113 20181113060040 ACCESSION NUMBER: 0001415889-18-001611 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181010 FILED AS OF DATE: 20181113 DATE AS OF CHANGE: 20181113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Korenko Michael K CENTRAL INDEX KEY: 0001486806 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-53497 FILM NUMBER: 181174593 MAIL ADDRESS: STREET 1: 6208 W OKANOGAN AVE CITY: KENNEWICK STATE: WA ZIP: 99336 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VIVOS INC CENTRAL INDEX KEY: 0001449349 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 800138937 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 719 JADWIN AVENUE CITY: RICHLAND STATE: WA ZIP: 99352 BUSINESS PHONE: 509-736-4000 MAIL ADDRESS: STREET 1: 719 JADWIN AVENUE CITY: RICHLAND STATE: WA ZIP: 99352 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICAL ISOTOPE Corp DATE OF NAME CHANGE: 20081103 4 1 form4-11132018_061102.xml X0306 4 2018-10-10 0001449349 VIVOS INC RDGL 0001486806 Korenko Michael K C/O VIVOS INC 719 JADWIN AVENUE RICHLAND WA 99352 false true false false CEO AND PRESIDENT Common Stock 2018-10-24 4 A 0 28197136 A 34427136 D Common Stock 2018-10-10 4 A 0 3600000 A 38027136 D Warrants 0.01 2018-10-24 4 A 0 14098568 A 2018-10-24 2020-10-24 Common Stock 14098568 14098568 D Options 0.014 2018-10-24 4 A 0 64961214 A 2018-10-24 2025-10-24 Common Stock 64961214 64961214 D Warrants 0.01 2018-10-10 4 A 0 1800000 A 2018-10-10 2020-10-10 Common Stock 1800000 1800000 D Represents securities issued in lieu of cash owed to the Reporting Person for past services rendered to the Issuer in his capacity as Chief Executive Officer and President. On October 10, 2018, in connection with a private placement consummated by the Issuer on such date, the Reporting Person agreed to terminate a bridge note with an outstanding balance of $15,000 ("Outstanding Balance") in exchange for the issuance of $18,000 of units, or 120% of the Outstanding Balance, consisting of 3,600,000 shares of the Issuer's common stock and warrants to purchase 1,800,000 shares of the Issuer's common stock. Represents securities issued to the Reporting Person as a bonus for services rendered to the Issuer in his capacity as Chief Executive Officer and President. /s/ Michael K. Korenko 2018-11-13